Psychiatric manifestations of paraneoplastic disorders

American Journal of Psychiatry

Volumn 167, Issue 9, 2010, Pages 1039-1050

  Kayser, Matthew S ^a   Kohler, Christian G ^a   Dalmau, Josep ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR ANTIBODY; AMPA RECEPTOR ANTIBODY; ANTIBODY; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5 ANTIBODY; CYCLOPHOSPHAMIDE; HU ANTIBODY; IMMUNOGLOBULIN; MA ANTIBODY; MEMBRANE ANTIGEN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY; AUTOANTIBODY; HU ANTIGEN; NERVE PROTEIN;

AUTOIMMUNITY; BREAST TUMOR; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GERM CELL TUMOR; HUMAN; HYPOTHALAMUS DISEASE; LUMBAR PUNCTURE; LUNG SMALL CELL CANCER; LUNG TUMOR; MOOD CHANGE; NERVE TUMOR; NEURAL CREST TUMOR; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPSOCLONUS MYOCLONUS SYNDROME; OVARY TERATOMA; PANCREAS CANCER; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; THYMOMA; TREATMENT OUTCOME; AUTOIMMUNE DISEASES; IMMUNOLOGY; LIMBIC ENCEPHALITIS; MENTAL DISORDERS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LIMBIC ENCEPHALITIS; MENTAL DISORDERS; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

EID: 77955780788     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.09101547     Document Type: Review

References (87)

1. Bakheit AM, Kennedy PG, Behan PO: Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry 1990; 53:1084-1088
2. Bataller L, Dalmau J: Paraneoplastic disorders of the memory and cognition, in The Behavioral Neurology of Dementia. Edited by Miller B, Boeve B. New York, Cambridge University Press, 2009, pp 377-394
3. Brierley J, Corsellis J, Hierons R, Nevin S: Subacute encephalitis of later adult life: mainly affecting the limbic areas. Brain 1960; 83:357-368
4. Corsellis JA, Goldberg GJ, Norton AR: "Limbic encephalitis" and its association with carcinoma. Brain 1968; 91:481-496
5. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349:1543-1554
6. Tuzun E, Dalmau J: Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007; 13:261-271 (Pubitemid 47396312)
7. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098
8. Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, Escaramis G, Delattre JY: Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124(pt 6):1138-1148
9. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR: Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004; 127(pt 8):1831-1844
10. Dalmau J, Bataller L: Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am 2006; 20:1319-1335 (Pubitemid 44739218)
11. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7:327-340
12. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75:1135-1140 (Pubitemid 39005770)
13. Cornelius JR, Soloff PH, Miewald BK: Behavioral manifestations of paraneoplastic encephalopathy. Biol Psychiatry 1986; 21:686-690
14. Newman NJ, Bell IR, McKee AC: Paraneoplastic limbic encephalitis: neuropsychiatric presentation. Biol Psychiatry 1990; 27:529-542
15. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123(pt 7):1481-1494
16. Alamowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY: Limbic encephalitis and small cell lung cancer: clinical and immunological features. Brain 1997; 120(pt 6):923-928
17. Bernal F, Graus F, Pifarre A, Saiz A, Benyahia B, Ribalta T: Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol 2002; 103:509-515
18. Voltz R, Dalmau J, Posner JB, Rosenfeld MR: T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1998; 51:1146-1150
19. Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY: Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999; 45:162-167 (Pubitemid 29072361)
20. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Mata S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J: AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65:424-434
21. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S: Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurol 2004; 62:1177-1182
22. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J: Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127(pt 3):701-712
23. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S: Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 2003; 78:1363-1368
24. Koide R, Shimizu T, Koike K, Dalmau J: EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol 2007; 81:71-74
25. Scheid R, Voltz R, Guthke T, Bauer J, Sammler D, von Cramon DY: Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis. Neurology 2003; 61:1159-1161 (Pubitemid 37461971)
26. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, Posner JB, Furneaux HM: HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 1991; 67:325-333
27. Dalmau J, Graus F, Rosenblum MK, Posner JB: Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore) 1992; 71:59-72
28. Sillevis Smitt P, Grefkens J, de Leeuw B, van den Bent M, van Putten W, Hooijkaas H, Vecht C: Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002; 249:745-753
29. Byrne T, Mason WP, Posner JB, Dalmau J: Spontaneous neurological improvement in anti-Hu associated encephalomyelitis. J Neurol Neurosurg Psychiatry 1997; 62:276-278
30. Vernino S, O'Neill BP, Marks RS, O'Fallon JR, Kimmel DW: Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol 2004; 6:55-62
31. Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, Posner JB, Dalmau J: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340:1788-1795 (Pubitemid 29266402)
32. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J: Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 2001; 50:339-348
33. Hoffmann LA, Jarius S, Pellkofer HL, Schueller M, Krumbholz M, Koenig F, Johannis W, la Fougere C, Newman T, Vincent A, Voltz R: Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 2008; 79:767-773
34. Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, Rossi JE, Thiessen B, Dropcho EJ, Dalmau J: Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 2007; 68:900-905
35. Compta Y, Iranzo A, Santamaria J, Casamitjana R, Graus F: REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep 2007; 30:767-769 (Pubitemid 46854764)
36. Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, Lammers GJ: Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004; 62:138-140
37. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E: A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6:991-997
38. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM: Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27:469-474
39. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD, Davis TL, Jiang A, Cohen MS, Stern CE, Belliveau JW, Baer L, O'Sullivan RL, Savage CR, Jenike MA, Rosen BR: Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53:595-606
40. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001; 49:146-154 (Pubitemid 32157990)
41. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM: Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995; 376:509-514
42. Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Boasberg P, Parisi JE, Lennon VA: Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002; 51:625-630
43. Nuti A, Ceravolo R, Salvetti S, Gambaccini G, Bonuccelli U, Capochiani E: Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord 2000; 15:350-352
44. Muehlschlegel S, Okun MS, Foote KD, Coco D, Yachnis AT, Fernandez HH: Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder. Mov Disord 2005; 20:1523-1527
45. Sabater L, Gomez-Choco M, Saiz A, Graus F: BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis. J Neuroimmunol 2005; 170(1-2):186-190
46. Crump JG, Zhen M, Jin Y, Bargmann CI: The SAD-1 kinase regulates presynaptic vesicle clustering and axon termination. Neuron 2001; 29:115-129
47. Tuzun E, Rossi JE, Karner SF, Centurion AF, Dalmau J: Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis. J Neuroimmunol 2007; 186(1-2):177-180 (Pubitemid 46770870)
48. Ren H, Wang L, Bennett M, Liang Y, Zheng X, Lu F, Li L, Nan J, Luo M, Eriksson S, Zhang C, Su XD: The crystal structure of human adenylate kinase 6: an adenylate kinase localized to the cell nucleus. Proc Natl Acad Sci USA 2005; 102:303-308
49. Dorresteijn LD, Kappelle AC, Renier WO, Gijtenbeek JM: Anti-amphiphysin associated limbic encephalitis: a paraneoplastic presentation of small-cell lung carcinoma. J Neurol 2002; 249:1307-1308
50. Antoine JC, Absi L, Honnorat J, Boulesteix JM, de Brouker T, Vial C, Butler M, De Camilli P, Michel D: Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol 1999; 56:172-177
51. Pittock SJ, Lucchinetti CF, Lennon VA: Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003; 53:580-587
52. Harloff A, Hummel S, Kleinschmidt M, Rauer S: Anti-Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung. J Neurol 2005; 252:1404-1405
53. Jarius S, Hoffmann L, Clover L, Vincent A, Voltz R: CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 2008; 268(1-2):74-77
54. Jacob S, Irani SR, Rajabally YA, Grubneac A, Walters RJ, Yazaki M, Clover L, Vincent A: Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 2008; 79:202-204
55. Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, Martinez-Rodriguez JE, Vincent A, Santamaria J: Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 2006; 59:178-181
56. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, Vincent A: Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001; 50:73-78
57. Gratacos E, Ghelardini C, Gherardini LM, Galeotti N, Murphy KJ, Bartolini A, Regan CM: Kv1.1 channel antisense attenuates learning and modulation of dentate polysialylated NCAM. Neuroreport 1998; 9:2727-2731 (Pubitemid 28435153)
58. Malenka RC, Bear MF: LTP and LTD: an embarrassment of riches. Neuron 2004; 44:5-21
59. Lau CG, Zukin RS: NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8:413-426
60. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J: Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005; 58:594-604
61. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66:11-18
62. Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, Collins A, Dengel A, Dalmau J, Glaser CA: Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28:1421-1429
63. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61:25-36 (Pubitemid 46214241)
64. Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U: A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 2008; 18:125-134 (Pubitemid 351413480)
65. Hallett PJ, Dunah AW, Ravenscroft P, Zhou S, Bezard E, Crossman AR, Brotchie JM, Standaert DG: Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 2005; 48:503-516
66. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA: Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981; 10:290-297
67. Olney JW, Newcomer JW, Farber NB: NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999; 33:523-533
68. Bredt DS, Nicoll RA: AMPA receptor trafficking at excitatory synapses. Neuron 2003; 40:361-379 (Pubitemid 37244101)
69. Kessels HW, Malinow R: Synaptic AMPA receptor plasticity and behavior. Neuron 2009; 61:340-350
70. Graus F, Saiz A, Lai M, Bruna J, Lopez F, Sabater L, Blanco Y, Rey MJ, Ribalta T, Dalmau J: Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 2008; 71:930-936
71. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J: Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology 2010; 9:67-76
72. Hussman JP: Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 2001; 31:247-248
73. Mitchell WG, Davalos-Gonzalez Y, Brumm VL, Aller SK, Burger E, Turkel SB, Borchert MS, Hollar S, Padilla S: Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics 2002; 109:86-98
74. Turkel SB, Brumm VL, Mitchell WG, Tavare CJ: Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia. J Neuropsychiatry Clin Neurosci 2006; 18:239-241 (Pubitemid 43749182)
75. Nunn K, Ouvrier R, Sprague T, Arbuckle S, Docker M: Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome? J Child Neurol 1997; 12:276-281
76. Sirvent N, Berard E, Chastagner P, Feillet F, Wagner K, Sommelet D: Hypothalamic dysfunction associated with neuroblastoma: evidence for a new paraneoplastic syndrome? Med Pediatr Oncol 2003; 40:326-328
77. Scholtz T, Pfeiffer F: Roentgenologic diagnosis of carcinoma of the tail of the pancreas. JAMA 1923; 81:275-277
78. Yaskin J: Nervous symptoms at earliest manifestations of cancer of the pancreas. JAMA 1931; 96:1664-1668
79. Fras I, Litin EM, Pearson JS: Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry 1967; 123:1553-1562
80. Green AI, Austin CP: Psychopathology of pancreatic cancer: a psychobiologic probe. Psychosomatics 1993; 34:208-221
81. Holland JC, Korzun AH, Tross S, Silberfarb P, Perry M, Comis R, Oster M: Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 1986; 143:982-986
82. Murru A, Castro P, Sanchez R, Benabarre A, Vieta E: Late-onset manic episode in a 91-year-old man without previous psychiatric history as a unique clinical manifestation of a pancreatic neoplasm. J Clin Psychiatry 2009; 70:296-297
83. Passik SD, Breitbart WS: Depression in patients with pancreatic carcinoma: diagnostic and treatment issues. Cancer 1996; 78(3 suppl):615-626
84. Benros ME, Laursen TM, Dalton SO, Mortensen PB: Psychiatric disorder as a first manifestation of cancer: a 10-year population-based study. Int J Cancer 2009; 124:2917-2922
85. Goldsmith CA, Rogers DP: The case for autoimmunity in the etiology of schizophrenia. Pharmacotherapy 2008; 28:730-741
86. Luo L, Callaway EM, Svoboda K: Genetic dissection of neural circuits. Neuron 2008; 57:634-660
87. Zhang F, Aravanis AM, Adamantidis A, de Lecea L, Deisseroth K: Circuit-breakers: optical technologies for probing neural signals and systems. Nat Rev Neurosci 2007; 8:577-581 (Pubitemid 47096597)